1. Home
  2. ALT vs MLP Comparison

ALT vs MLP Comparison

Compare ALT & MLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALT
  • MLP
  • Stock Information
  • Founded
  • ALT 1997
  • MLP 1909
  • Country
  • ALT United States
  • MLP United States
  • Employees
  • ALT N/A
  • MLP N/A
  • Industry
  • ALT Biotechnology: Pharmaceutical Preparations
  • MLP Real Estate
  • Sector
  • ALT Health Care
  • MLP Finance
  • Exchange
  • ALT Nasdaq
  • MLP Nasdaq
  • Market Cap
  • ALT 292.0M
  • MLP 344.7M
  • IPO Year
  • ALT N/A
  • MLP 1972
  • Fundamental
  • Price
  • ALT $3.67
  • MLP $17.18
  • Analyst Decision
  • ALT Strong Buy
  • MLP
  • Analyst Count
  • ALT 6
  • MLP 0
  • Target Price
  • ALT $17.40
  • MLP N/A
  • AVG Volume (30 Days)
  • ALT 2.8M
  • MLP 17.4K
  • Earning Date
  • ALT 08-12-2025
  • MLP 08-14-2025
  • Dividend Yield
  • ALT N/A
  • MLP N/A
  • EPS Growth
  • ALT N/A
  • MLP N/A
  • EPS
  • ALT N/A
  • MLP N/A
  • Revenue
  • ALT $20,000.00
  • MLP $16,843,000.00
  • Revenue This Year
  • ALT N/A
  • MLP N/A
  • Revenue Next Year
  • ALT $761,880.20
  • MLP N/A
  • P/E Ratio
  • ALT N/A
  • MLP N/A
  • Revenue Growth
  • ALT N/A
  • MLP 74.59
  • 52 Week Low
  • ALT $2.90
  • MLP $14.05
  • 52 Week High
  • ALT $11.16
  • MLP $26.46
  • Technical
  • Relative Strength Index (RSI)
  • ALT 46.45
  • MLP 53.45
  • Support Level
  • ALT $3.35
  • MLP $15.65
  • Resistance Level
  • ALT $3.66
  • MLP $17.21
  • Average True Range (ATR)
  • ALT 0.18
  • MLP 0.55
  • MACD
  • ALT 0.05
  • MLP 0.06
  • Stochastic Oscillator
  • ALT 58.57
  • MLP 78.06

About ALT Altimmune Inc.

Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.

About MLP Maui Land & Pineapple Company Inc.

Maui Land & Pineapple Co Inc is a landholding and operating company. ML&P owns, develops, sells, and manages residential, resort, commercial, agricultural, and industrial real estate. It operates in three segments: Land Development & Sales which includes land planning and entitlement, development, and sales activities; Leasing operations include residential, resort, commercial, agricultural, industrial land and property leases; and Resort Amenities segment, which include a membership program that provides certain benefits and privileges within the Kapalua Resort for its members. The majority of its revenue is derived from the Leasing segment. Leasing revenue is generated from restaurants, retail outlets, office buildings, warehouses, and other resort activities.

Share on Social Networks: